Thomas Wayne Gibbs
Direktor/Vorstandsmitglied bei Biocartis SA
Ursprung des Netzwerks ersten Grades von Thomas Wayne Gibbs
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
Biocartis SA
 Biocartis SA Medical SpecialtiesHealth Technology Biocartis SA develops molecular diagnostic solutions. It focuses on Oncology. The firm’s products include Idylla and Oncology assays and mutation tests. It also provides instant access to personalized medicine for patients. The company was founded by Rudi Pauwels in 2007 and is headquartered in Lausanne, Switzerland.
19
| Subsidiary | Medical Specialties | 19 |
Immunexpress Pty Ltd.
 Immunexpress Pty Ltd. Medical SpecialtiesHealth Technology Immunexpress Pty Ltd. engages in creating molecular diagnostics for sepsis. The company was founded by Roslyn Brandon, Mervyn Rees Thomas and Richard Bruce Brandon and in 2006 and is headquartered in Toowong, Australia.
11
| Subsidiary | Medical Specialties | 11 |
Immunexpress, Inc.
 Immunexpress, Inc. Miscellaneous Commercial ServicesCommercial Services Immunexpress, Inc. engages in development of revolutionary molecular diagnostics. The firm's SeptiCyte technology quantifies specific and multiple molecular markers from the patient?s own immune system for earlier detection and severity assessment of sepsis, as well as the better timing of drugs and other therapies. The company was founded by Richard Bruce Brandon, Roslyn Brandon and Mervyn Rees Thomas in and is headquartered in
7
| Holding Company | Miscellaneous Commercial Services | 7 |
Debiopharm Innovation Fund /Management/
 Debiopharm Innovation Fund /Management/ Investment ManagersFinance Debiopharm Innovation Fund SA develops, manufactures, and markets diagnostic systems. It seeks to invest in the biotechnology, diagnostics, and pharmaceutical industries with a focus on biomarker development, and large molecule capabilities. The firm mission is to invest in innovative diagnostic companies developing platforms and content to complement in-house diagnostic activities, give insight into cutting-edge diagnostics and facilitate access to new technologies. The company was founded in 1979 and is headquartered in Fribourg, Switzerland.
5
| Subsidiary | Investment Managers | 5 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Thomas Wayne Gibbs
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| ABBOTT LABORATORIES | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal | |
| TRINITY BIOTECH PLC | Medical Specialties | Director/Board Member | |
Advent Venture Partners LLP
 Advent Venture Partners LLP Investment ManagersFinance Advent Venture Partners LLP (AVP) is a private equity/venture capital firm founded in 1981 by David James Scott Cooksey. The firm is headquartered in London, United Kingdom. | Investment Managers | Private Equity Investor Private Equity Investor | |
WaferGen, Inc.
 WaferGen, Inc. BiotechnologyHealth Technology WaferGen, Inc. develops novel products for cell biology and genetic analysis. The firm focuses on the development systems for gene expression, genotyping and stem cell research for the life science and pharmaceutical industries. The company was founded by Alnoor Shivji, Victor Joseph and Amjad Huda and is headquartered in Fremont, CA. | Biotechnology | Chief Executive Officer | |
| Warwick Business School | College/University | Masters Business Admin | |
Asuragen, Inc.
 Asuragen, Inc. Medical SpecialtiesHealth Technology Asuragen, Inc. develops molecular diagnostic products. Its products include AmplideX and QuantideX. It uses genomics to drive patient management through clinical testing solutions. The company was founded in March 2006 by Matthew M. Winkler and is headquartered in Austin, TX. | Medical Specialties | Chief Tech/Sci/R&D Officer Chief Executive Officer | |
| GALAPAGOS NV | Biotechnology | Chairman Founder | |
| MDXHEALTH SA | Medical Specialties | Director/Board Member Director/Board Member Director/Board Member Chairman | |
Johnson & Johnson Innovation - JJDC, Inc.
 Johnson & Johnson Innovation - JJDC, Inc. Investment ManagersFinance Johnson & Johnson Innovation JJDC Inc (Johnson & Johnson Innovation JJDC) is a venture capital subsidiary of Johnson & Johnson founded in 1973. The firm is headquartered in New Brunswick, New Jersey. | Investment Managers | Corporate Officer/Principal | |
Fujirebio Europe NV
 Fujirebio Europe NV Medical SpecialtiesHealth Technology Fujirebio Europe NV develops and markets diagnostic products to improve therapy management and patient health. It focuses on molecular diagnostics and multiparameter testing. The firm also provides LUMIPULSE G1200, an automated chemiluminescent enzyme immunoassay system; LUMIPULSE G600 II, an automated benchtop CLEIA system, routine and novel markers for the oncology sector. The company was founded in 1985 by Philippe Leboulch and is headquartered in Ghent, Belgium. | Medical Specialties | Founder Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
University of Melbourne
 University of Melbourne Other Consumer ServicesConsumer Services The University of Melbourne, founded in 1853, is a world-renowned institution located in Parkville, Australia. The university is a leader in education, teaching, and research, offering a wide range of coursework and research programs. | College/University | Masters Business Admin | |
AchieveGlobal, Inc.
 AchieveGlobal, Inc. Miscellaneous Commercial ServicesCommercial Services AchieveGlobal, Inc. provides soft skills training and consulting services. It offers consulting and training programs for companies generate measurable results in sales performance, customer service, leadership development, and organizational effectiveness. The company has offices in Boston, Chicago, Dallas, Philadelphia, Salt Lake City, and San Francisco. AchieveGlobal was founded in 1963 and is located in Tampa, FL | Miscellaneous Commercial Services | Founder | |
Debiopharm International SA
 Debiopharm International SA Pharmaceuticals: MajorHealth Technology Debiopharm International SA operates as a biopharmaceutical development company with focus on biologics and drug evaluation, licensing and development. It formulates and develops products for the treatment of cancer, endometriosis, uterine fibroids and hepatitis. The company was founded in 1979 and is headquartered in Lausanne, Switzerland. | Pharmaceuticals: Major | Founder Chairman Corporate Officer/Principal | |
| James Cook University | College/University | Undergraduate Degree | |
| Yale University | College/University | Undergraduate Degree | |
| Southern Illinois University | College/University | Doctorate Degree | |
deVGen NV
 deVGen NV BiotechnologyHealth Technology deVGen NV provides biotechnology services for the pharmaceutical and agrochemical industries. It innovates in crop protection research and environment induced stress tolerance for its own crops and provides technology to corporate partners. The firm produces and sells its hybrid seeds in field crops such as rice, sunflower, sorghum and pearl millet in the Indian subcontinent and Southeast Asia. The company was founded by Thierry Bogaert on September 10, 1997 and is headquartered in Ghent, Belgium. | Biotechnology | Director/Board Member Director/Board Member | |
| ABLYNX | Biotechnology | Director/Board Member Corporate Officer/Principal | |
| Queensland University of Technology | College/University | Undergraduate Degree | |
| Ghent University | College/University | Undergraduate Degree Graduate Degree Graduate Degree Graduate Degree Graduate Degree Doctorate Degree Doctorate Degree | |
| Katholieke Universiteit Leuven | College/University | Doctorate Degree Doctorate Degree Graduate Degree Graduate Degree | |
| OXURION NV | Pharmaceuticals: Major | Chairman | |
Vlaams Instituut voor Biotechnologie - Flanders Institute
 Vlaams Instituut voor Biotechnologie - Flanders Institute Other Consumer ServicesConsumer Services Vlaams Instituut voor Biotechnologie - Flanders Institute operates as a non-profit organization, provides research and development services. It specializes in translating basic scientific results into pharmaceutical, agricultural and industrial applications. The company was founded on January 1, 1996 and is headquartered in Ghent, Belgium. | College/University | Director/Board Member | |
MyCartis NV
 MyCartis NV BiotechnologyHealth Technology MyCartis NV develops technologies for healthcare personalization needs. It offers Evalution, a multiplex analysis platform to develop protein and nucleic-acid based clinical biomarkers. The company provides disruptive solutions in the fields of clinical and translational research for various applications in the detection of proteins and nucleic acids, such as sandwich immunoassays, antibody assays, genotyping assays, and mutation analysis assays to customers and partners. It offers products for various disease areas, including cell signalling, cardiovascular, oncology, and preeclampsia. The company was founded by Koen Kas in August 2004 and is headquartered in Ghent, Belgium. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member Chief Executive Officer | |
Intrexon ActoBiotics NV
 Intrexon ActoBiotics NV BiotechnologyHealth Technology Intrexon ActoBiotics NV manufactures biopharmaceutical products. It focuses on the development and commercialization of a new generation of biological drugs. The company represents a novel concept for oral administration of therapeutic proteins, and is designed to be safer and more effective than injectable biopharmaceuticals. Intrexon Actobioticswas founded by Mark Vaeck, Emil Pot and Bernard Coulie in June 2006 and is headquartered in Zwijnaarde, Belgium. | Biotechnology | Director/Board Member Director/Board Member Chairman | |
Janssen Pharmaceutica NV
 Janssen Pharmaceutica NV Pharmaceuticals: MajorHealth Technology Janssen Pharmaceutica NV engages in the development of medical solutions. It offers research and development services in the field of mental illness, neurological disorders, anesthesia, analgesia, gastrointestinal disorders, fungal infection, allergies and cancer. The firms products include Zytiga, Caelyx, Dacogen, Edurant, Fentanyl-Janssen, Intelence, Leustatin, , Pariet, and Reminyl. The company was founded in 1953 by Paul Janssen and is headquartered in Beerse, Belgium. | Pharmaceuticals: Major | Chief Executive Officer | |
| The Janssen Research Foundation | President | ||
Timsco Pty Ltd.
 Timsco Pty Ltd. Investment ManagersFinance Timsco Pty Ltd is venture capital firm founded in 2000 by Mr. Rick Anstey & Mr. Laurie Hammond. The firm is headquartered in Varsity Lakes, Queensland. | Investment Managers | Founder | |
Cleveland Biosensors Pty Ltd.
 Cleveland Biosensors Pty Ltd. BiotechnologyHealth Technology Cleveland Biosensors Pty Ltd. develops and distributes biosensor instruments. It offers Biofiniti, a portable point-of-care diagnostic system that enables the early diagnosis of disease and health disorders in a range of clinical settings, as well as performs tests on a small disposable cartridge that contains various necessary reagents. The firm's hand-held instrument BioFiniti, allows users to conduct rapid, analysis on a wide variety of samples. The company was founded in 2001 and is headquartered in Brisbane, Australia. | Biotechnology | Chairman | |
FlandersBio vzw
 FlandersBio vzw Miscellaneous Commercial ServicesCommercial Services FlandersBio vzw is a life sciences cluster organization based in Flanders, Belgium. FlandersBio creates value by organizing networking and training activities, supporting internationalization, providing services, and building expertise. The Belgian company was founded by Jean Marie Stassen. | Miscellaneous Commercial Services | Director/Board Member Chairman | |
| University Of The West Indies | College/University | Doctorate Degree | |
| Viziphar Biosciences BV | Chief Executive Officer | ||
| Vivactis NV | Miscellaneous | Director/Board Member | |
| University of Antwerp | College/University | Graduate Degree Graduate Degree Graduate Degree | |
Commercialisation Australia
 Commercialisation Australia Miscellaneous Commercial ServicesCommercial Services Commercialisation Australia offers funding and resources to accelerate the business building process. It also encourages and assists small and medium businesses, entrepreneurs and researchers to commercialize novel products, processes and services. The company is headquartered in Australia, | Miscellaneous Commercial Services | Director/Board Member | |
Pristine, Inc.
 Pristine, Inc. Packaged SoftwareTechnology Services Pristine, Inc. provides enterprise software solutions for smart glasses. Its product EyeSight, offers industrial and healthcare solutions. The firm offers video communication platform primarily for health care providers, delivering information and allowing communication on the device's optics. The company was founded by Kyle Samani and Patrick Kolencherry in 2013 and is headquartered in Austin, TX. | Packaged Software | Director/Board Member | |
| BIOCARTIS GROUP NV | Medical Specialties | Director/Board Member Director/Board Member Chairman Director/Board Member Chief Executive Officer Director/Board Member Director/Board Member Director/Board Member Director/Board Member Chief Tech/Sci/R&D Officer Chief Operating Officer Director/Board Member | |
| ECHO IQ LIMITED | Other Metals/Minerals | Director/Board Member | |
PharmaFluidics NV
 PharmaFluidics NV Electronic Equipment/InstrumentsElectronic Technology Pharmafluidics NV develops micro chip liquid chromatography cartridges for analysis of complex biological samples. The company was founded by Wim De Malsche, Joeri Denayer, Gert Desme and Paul Godelieve Jacobs in 2010 and is headquartered in Ghent, Belgium. | Electronic Equipment/Instruments | Director/Board Member Chairman | |
Straxcorp Pty Ltd.
 Straxcorp Pty Ltd. Packaged SoftwareTechnology Services Part of Curvebeam AI Ltd., Straxcorp Pty Ltd. is an Australian company that is described as "! The company is based in Melbourne, Australia. the new company is curvebeam ai." The CEO of the company is Gregory Wayne Brown. Straxcorp was acquired by Curvebeam LLC on October 12, 2022 for $12.67 million. | Packaged Software | Chief Executive Officer | |
| CURVEBEAM AI LIMITED | Biotechnology | Chairman Chief Executive Officer | |
HWH Software Pty Ltd.
 HWH Software Pty Ltd. Packaged SoftwareTechnology Services HWH Software Pty Ltd. operates as a software developer company. It serves individuals, businesses and the government. The company was founded on December 8, 2005 and is headquartered in Sydney, Australia. | Packaged Software | Director/Board Member |
Statistik
International
| Belgien | 24 |
| Vereinigte Staaten | 14 |
| Australien | 10 |
| Vereinigtes Königreich | 3 |
| Irland | 2 |
Sektoral
| Health Technology | 21 |
| Consumer Services | 12 |
| Commercial Services | 7 |
| Finance | 5 |
| Technology Services | 4 |
Operativ
| Director/Board Member | 153 |
| Corporate Officer/Principal | 52 |
| Chairman | 38 |
| Chief Executive Officer | 33 |
| Founder | 28 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Raj Bhikhu Parekh | 50 |
| Rudi Mariën | 31 |
| Staf van Reet | 22 |
| Rudi Pauwels | 19 |
| Ruth Devenyns | 18 |
| Domenico Valerio | 15 |
| Peter Piot | 14 |
| Greg Brown | 14 |
| Robert McG. Lilley | 11 |
| Laurie Hammond | 10 |
| Christine Deuschel Cornioley | 10 |
| Renaat Berckmoes | 9 |
| Rolland D. Carlson | 8 |
| Tanja Dowe | 8 |
| Mark Shaffar | 7 |
- Börse
- Insiders
- Thomas Wayne Gibbs
- Unternehmensverbindungen
